KNW - Utang jangka dawa perusahaan Know Labs Corp

Tandha merek Know Labs Corporation (KNW)

Know Labs, Inc. (KNW) is currently undergoing the validation phase for the effectiveness of its innovative optical sugar monitoring system. As the company is just entering the market, its financial metrics remain volatile until the product achieves widespread adoption. The price action on GURU.Markets, where long-term debt stands at 0.00, confirms the risk of dependence on external assemblers while the company maintains full control over the software code.

KNW Know Labs Corp: Utang jangka dawa perusahaan ing interval 28.04.2023 - 15.08.2025
Produk seri Know Labs Inc

Investors assess fundamental capital risks through the analysis of debt load. For Know Labs, Inc. (KNW), which is transitioning toward the commercialization of glucose monitoring systems amid volatile revenues, this factor is critical. The dynamics of the firm's long-term borrowings measure obligations with a maturity of more than one year, capturing the current value of 0.00. An increase in this metric indicates a risk of default, while its minimum suggests limited resources for scaling. The debt balance determines the issuer's financial stability.

Analisis pesaing Know Labs, Inc.

Silihan lan utang jangka dawa perusahaan dexcom.com DXCM|Penumbra - Utang jangka dawa perusahaan|NOVT: Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Haemonetics Corp. (HAE)|Inspire Medical Systems Inc (INSP) - Kewajiban jangka dawa|Utang jangka dawa perusahaan PRCT (PROCEPT BioRobotics)|Utang jangka dawa conmed.com (CNMD)|Kewajiban jangka dawa perusahaan PLSE|Utang jangka dawa perusahaan InMode Ltd INMD|Kewajiban jangka dawa perusahaan Picard Medical Inc. (PMI)|Gedhene kewajiban jangka dawa Surmodics Inc. SRDX|Utang jangka dawa perusahaan SENS (Senseonics Holdings, Inc.)|NPCE - Gunggunge utang jangka dawa|TCMD (tactilemedical.com) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan SANUWAVE Health|OM - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ELMD|Utang jangka dawa perusahaan LNSR (LENSAR, Inc.)|Kewajiban jangka dawa perusahaan avitamedical.com (RCEL)|PROF: Utang jangka dawa perusahaan|Utang jangka dawa Baird Medical Investment Holdings BDMD|EDAP Medical (EDAP) - Utang jangka dawa perusahaan|APYX - Tanggungan utang jangka dawa perusahaan|icecure-medical.com - Utang jangka dawa perusahaan|Pulmonx (LUNG) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan TELA|Kewajiban jangka dawa perusahaan CytoSorbents Corp.|Utang jangka dawa perusahaan SRTS|Utang jangka dawa perusahaan ZYXI (Zynex Corp)|Utang jangka dawa perusahaan electroCore ECOR|RBOT - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Inspira Technologies Oxy B.H.N. Ltd (IINN)|ICU - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan IRIX|INBS (Intelligent Bio Solutions Inc.) - Utang jangka dawa|Beyond Air Inc - Utang jangka dawa perusahaan|Tanggungan jangka dawa profusa.com (PFSA)|Kewajiban jangka dawa perusahaan SSKN|Utang jangka dawa perusahaan GlucoTrack Inc. (GCTK)|Utang jangka dawa perusahaan NAOV|Venus Concept Corporation - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan Nuwellis, Inc.|AEMD: Kewajiban jangka dawa|ASXC (asensus.com) - Utang jangka dawa perusahaan|Avinger Inc. (AVGR) - Kewajiban jangka dawa perusahaan|Utang jangka dawa perusahaan BSGM (BioSig Technologies)|Utang jangka dawa CUTR|Utang jangka dawa perusahaan Inari Medical, Inc. NARI|Tanggungan utang jangka dawa perusahaan nevro.com NVRO|Kewajiban jangka dawa perusahaan ReShape Lifesciences Inc. (RSLS)|Silk Road Medical, Inc. - Gedhene kewajiban jangka dawa